Article info
PDFLetter
Non-compliance: a side effect of drug information leaflets
- Correspondence to: Dr F Verdú Department of Legal Medicine, College of Medicine and Odontology, University of Valencia E G, Av/ Blasco Ibañez, n°15, 46010-Valencia (Spain); Fernando.Verduuv.es
Citation
Non-compliance: a side effect of drug information leaflets
Publication history
- First published November 30, 2004.
Online issue publication
November 30, 2004
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2004 by the Journal of Medical Ethics
Other content recommended for you
- Unethical informed consent caused by overlooking poorly measured nocebo effects
- Informed consent and clinical trials: where is the placebo effect?
- What trial participants need to be told about placebo effects to give informed consent: a survey to establish existing knowledge among patients with back pain
- Are patient information leaflets contributing to informed consent for cataract surgery?
- Development of consumer information leaflets for deprescribing in older hospital inpatients: a mixed-methods study
- The nocebo effect: patient expectations and medication side effects
- Patient information leaflets to reduce antibiotic use and reconsultation rates in general practice: a systematic review
- Patient information leaflets: “a stupid system”
- Patients’ adherence-related beliefs about methotrexate: a qualitative study of the role of written patient information
- A review of recorded information given to patients starting to take clozapine and the development of guidelines on disclosure, a key component of informed consent